Last updated on August 2012

Study Assessing the Efficacy of Etoricoxib in Female Patients With Fibromyalgia


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Fibromyalgia
  • Age: Between 18 - 75 Years
  • Gender: Female
  • Other:
    • Women with established primary FMS who signed an informed consent form
    Women 18-75 years old.
    The score on the average pain severity item of the BPI is > 5 at randomization.
    Patients on stable physical therapy or anelgestic pain treatment throughout the
    duration of the study.

You may not be eligible for this study if the following are true:

  • • Confirmed pregnancy
    Breast feeding patients
    Patients with active coronary artery disease with documented myocardial ischemia
    proven by coronary angiography, thallium scan or exercise stress test.
    Patients with congestive heart failure
    Patients with coexistent neoplastic conditions (not including basal cell
    carcinoma)
    Patients with coexistent t rheumatic/inflammatory conditions
    Patients with active gastrointestinal bleeding
    Patients with renal failure
    Patients with comorbid conditions causing significant disability
    Patients with uncontrolled hypertension.
    Patient with contraindications for the trial drug based on the drug's physician
    leaflet.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.